Position in MGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$869,433
+$730,679 QoQ
Shares Held
188,189
+292.0% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 122 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,100,351,284 across 114 Biotechnology names. MGNX ranks #84 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in MGNX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $869,433 | 188,189 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $138,754 | 48,012 | Shares | Defined | 2026-05-15 | |
| 2022-09-30 | $69,892 | 20,200 | Shares | Sole | 2022-11-14 | |
| 2020-12-31 | $1,842,950 | 80,619 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,681,230 | 66,742 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,970,956 | 70,593 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,110,234 | 190,762 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||